Epigenetic modifications and their role in cancer
Professor Tony Kouzarides, FMedSci, FRS
Tony is Professor of Cancer Biology at the University of Cambridge and a group leader at the Gurdon Institute. He currently holds the following directorships: Director and co-founder of the Milner Therapeutics Institute, director of Cambridge Gravity, and director of STORM Therapeutics.
Other TK Enterprises:
Selected publications:
• Barbieri I et al. (2020) Role of ENA modifications in cancer. Nature Cancer Cell, published online.
• Pandolfini L et al. (2019) METTL1 promotes let-7 microRNA processing via m7G methylation. Molecular Cell 25 April. DOI: 10.1016/j.molcel.2019.03.040.
• Barbieri I et al. (2017) Promoter-bound METTL3 maintains myeloid leukaemia by m6A-dependent translation control. Nature 552, 126–131.
Twitter:
[fts_twitter twitter_name=TKLABUK tweets_count=3 twitter_height=400px cover_photo=no stats_bar=no show_retweets=yes show_replies=no]
The Gurdon Institute
Tennis Court Road
Cambridge, CB2 1QN
United Kingdom
Phone: +44 (0) 1223 334088
Fax: +44 (0) 1223 334089